ArticleJournal of pharmaceutical health care and sciences2025
Insights into stress ulcer prophylaxis among non-critically ill patients: a tertiary hospital perspective from Sudan.
Article in Journal of pharmaceutical health care and sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Proton pump inhibitor use and risk of depression among Sudanese adults: a cross-sectional community-based study.Frontiers in psychiatry · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAcid-suppressive therapy (AST) is often used without proper assessment of the need, dosage, or duration of treatment. This inappropriate use can lead to significant side effects, harmful drug interactions, and increased healthcare costs for patients.
objectiveThis study aimed to evaluate stress ulcer prophylaxis (SUP) among hospitalized adult patients who were non-critically ill.
methodThis hospital-based, retrospective cross-sectional study was conducted in general internal medicine wards at Atbara Teaching Hospital, Sudan, from September to December 2024. The study included all hospitalized adult patients who received AST for SUP.
resultsIn total, 221 patients were evaluated in this study; among them, 136 (61%) were males and 75 (34%) were aged 61–80 years. Overall, only 84 patients (38%) were eligible for SUP, with pantoprazole 214 (97%) and intravenous (IV) route 215 (97.3%) being the most commonly used. Anticoagulant 48 (22%) and steroid or NSAID 20 (9%) use were the most and least the common risk factors based on ASHP criteria, respectively. A statistically significant association was found with polypharmacy (P < 0.001); 116 (52%) had polypharmacy, of whom 80 (69%) were eligible for SUP, and significant associations were also identified with other clinical characteristics, such as past medical history (P < 0.001) and sepsis (P = 0.013).
conclusionThis study revealed a high rate of inappropriate SUP prescriptions among non-ICU patients in a Sudanese hospital, with IV pantoprazole being the most used. These findings emphasize the need for evidence-based protocols, greater clinical pharmacist involvement, and interdisciplinary efforts to improve the appropriateness and cost-effectiveness of SUP use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.